author_facet Gamez, Josep
Salvadó, María
Reig, Núria
Suñé, Pilar
Casasnovas, Carles
Rojas-Garcia, Ricard
Insa, Raúl
Gamez, Josep
Salvadó, María
Reig, Núria
Suñé, Pilar
Casasnovas, Carles
Rojas-Garcia, Ricard
Insa, Raúl
author Gamez, Josep
Salvadó, María
Reig, Núria
Suñé, Pilar
Casasnovas, Carles
Rojas-Garcia, Ricard
Insa, Raúl
spellingShingle Gamez, Josep
Salvadó, María
Reig, Núria
Suñé, Pilar
Casasnovas, Carles
Rojas-Garcia, Ricard
Insa, Raúl
Amyloid
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
Internal Medicine
author_sort gamez, josep
spelling Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl 1350-6129 1744-2818 Informa UK Limited Internal Medicine http://dx.doi.org/10.1080/13506129.2019.1597702 Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study Amyloid
doi_str_mv 10.1080/13506129.2019.1597702
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI
institution DE-15
DE-Pl11
DE-Rs1
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-D161
DE-Gla1
DE-Zi4
imprint Informa UK Limited, 2019
imprint_str_mv Informa UK Limited, 2019
issn 1350-6129
1744-2818
issn_str_mv 1350-6129
1744-2818
language English
mega_collection Informa UK Limited (CrossRef)
match_str gamez2019transthyretinstabilizationactivityofthecatecholomethyltransferaseinhibitortolcaponesom0226inhereditaryattramyloidosispatientsandasymptomaticcarriersproofofconceptstudy
publishDateSort 2019
publisher Informa UK Limited
recordtype ai
record_format ai
series Amyloid
source_id 49
title Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_unstemmed Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_full Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_fullStr Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_full_unstemmed Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_short Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_sort transthyretin stabilization activity of the catechol-<i>o</i>-methyltransferase inhibitor tolcapone (som0226) in hereditary attr amyloidosis patients and asymptomatic carriers: proof-of-concept study
topic Internal Medicine
url http://dx.doi.org/10.1080/13506129.2019.1597702
publishDate 2019
physical 74-84
description
container_issue 2
container_start_page 74
container_title Amyloid
container_volume 26
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792344876899106818
geogr_code not assigned
last_indexed 2024-03-01T17:14:02.564Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Transthyretin+stabilization+activity+of+the+catechol-O-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&rft.date=2019-04-03&genre=article&issn=1744-2818&volume=26&issue=2&spage=74&epage=84&pages=74-84&jtitle=Amyloid&atitle=Transthyretin+stabilization+activity+of+the+catechol-%3Ci%3EO%3C%2Fi%3E-methyltransferase+inhibitor+tolcapone+%28SOM0226%29+in+hereditary+ATTR+amyloidosis+patients+and+asymptomatic+carriers%3A+proof-of-concept+study&aulast=Insa&aufirst=Ra%C3%BAl&rft_id=info%3Adoi%2F10.1080%2F13506129.2019.1597702&rft.language%5B0%5D=eng
SOLR
_version_ 1792344876899106818
author Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl
author_facet Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl, Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl
author_sort gamez, josep
container_issue 2
container_start_page 74
container_title Amyloid
container_volume 26
description
doi_str_mv 10.1080/13506129.2019.1597702
facet_avail Online
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA4MC8xMzUwNjEyOS4yMDE5LjE1OTc3MDI
imprint Informa UK Limited, 2019
imprint_str_mv Informa UK Limited, 2019
institution DE-15, DE-Pl11, DE-Rs1, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Gla1, DE-Zi4
issn 1350-6129, 1744-2818
issn_str_mv 1350-6129, 1744-2818
language English
last_indexed 2024-03-01T17:14:02.564Z
match_str gamez2019transthyretinstabilizationactivityofthecatecholomethyltransferaseinhibitortolcaponesom0226inhereditaryattramyloidosispatientsandasymptomaticcarriersproofofconceptstudy
mega_collection Informa UK Limited (CrossRef)
physical 74-84
publishDate 2019
publishDateSort 2019
publisher Informa UK Limited
record_format ai
recordtype ai
series Amyloid
source_id 49
spelling Gamez, Josep Salvadó, María Reig, Núria Suñé, Pilar Casasnovas, Carles Rojas-Garcia, Ricard Insa, Raúl 1350-6129 1744-2818 Informa UK Limited Internal Medicine http://dx.doi.org/10.1080/13506129.2019.1597702 Transthyretin stabilization activity of the catechol-<i>O</i>-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study Amyloid
spellingShingle Gamez, Josep, Salvadó, María, Reig, Núria, Suñé, Pilar, Casasnovas, Carles, Rojas-Garcia, Ricard, Insa, Raúl, Amyloid, Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study, Internal Medicine
title Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_full Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_fullStr Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_full_unstemmed Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_short Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_sort transthyretin stabilization activity of the catechol-<i>o</i>-methyltransferase inhibitor tolcapone (som0226) in hereditary attr amyloidosis patients and asymptomatic carriers: proof-of-concept study
title_unstemmed Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
topic Internal Medicine
url http://dx.doi.org/10.1080/13506129.2019.1597702